
khunkornStudio // Shutterstock
For many healthcare organizations, website consent appears to be a settled issue. A cookie banner is displayed, a privacy policy is linked, and users are given basic choices about tracking. On paper, this approach may seem sufficient.
Under HIPAA, however, that assumption does not always hold.
By the end of 2025, the U.S. Department of Health and Human Services had recorded at least 642 large healthcare data breaches affecting 57 million individuals.
As healthcare providers, insurers, and digital health companies expand their online presence, regulators and privacy experts have raised concerns about how patient-related data is collected and shared through websites. In particular, the use of analytics and tracking technologies has drawn increased scrutiny, exposing a gap between standard cookie consent practices and HIPAA’s authorization requirements.
HIPAA authorization is a specific legal concept. It applies when protected health information is disclosed to third parties for purposes beyond treatment, payment, or healthcare operations. Unlike general website consent, authorization must be explicit, informed, and documented.
Cookie consent tools, by contrast, were largely developed to address consumer privacy laws governing online tracking and advertising. They are designed to manage cookies and similar technologies, not to capture HIPAA-specific authorization related to healthcare data.
Clym explains this distinction, which has become more significant as healthcare websites increasingly rely on third-party services for analytics, marketing, and user experience optimization.
When Website Tracking Can Involve Protected Health Information
HIPAA is often associated with electronic medical records and patient portals, but privacy specialists note that website interactions can also involve protected health information, depending on context.
An IP address combined with visits to condition-specific pages, appointment scheduling tools, or symptom-related content may reveal information about an individual’s health interests. When that data is transmitted to third-party platforms, even unintentionally, HIPAA authorization considerations can arise.
Regulators have emphasized that the focus is on the data itself, not the medium through which it is collected. Whether information is collected through a form, a tracking pixel, or an analytics script, the same principles apply.
Why Simple Cookie Banners Often Fall Short
Most standard cookie consent banners are not designed to address these scenarios. They typically provide broad disclosures and generic acceptance options, without distinguishing between marketing consent and authorization to share health-related data.
Privacy professionals point out that cookie consent tools generally lack: